ABSTRACT Introduction 5α-reductase inhibitors (5α-RIs), finasteride and dutasteride, have
been approved for treatment of lower urinary tract symptoms, due to benign prostatic …

Objective Testosterone has a spectrum of effects on the male organism. This review attempts
to determine, from published studies, the time-course of the effects induced by testosterone …

Introduction Late‐onset hypogonadism (LOH) is diagnosed when declining testosterone
concentrations in the aging male cause unwanted symptoms such as erectile dysfunction …

Introduction Sexual dysfunction, particularly erectile dysfunction (ED), is common in men
with type 2 diabetes, occurring in up to 75% of cases. The prevalence of hypogonadism is …

Background The association between testosterone deficiency and insulin resistance in men
with type 2 diabetes is well established. Current Endocrine Society and European …

Introduction Male hypogonadism is a common condition, with an increasing body of
literature on diagnosis, implications, and management. Given the significant variability in …

Obesity is associated with a high prevalence of erectile dysfunction; however, the
pathophysiological link between obesity and erectile dysfunction remains poorly …

Introduction In the era of orally active agents, dynamic penile color-duplex ultrasound (D-
PCDU) is not considered a necessary first screening for all patients with erectile dysfunction …

ABSTRACT Introduction The contractile RhoA/Rho-kinase (ROCK) signaling pathway is
upregulated in penile tissue in animal models of experimental diabetes and has been …

Introduction The long-term effects of long-acting testosterone undecanoate (TU) and
androgen receptor CAG repeat lengths in Thai men with late-onset hypogonadism (LOH) …